Alethea Capital’s Series A investment into 3X4 Genetics’ operations in South Africa for USD 2.5 million

Lead party: Alitheia Capital Limited (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Cipher Genetics, Inc. (private company) · Sector: Healthcare, Digital Health Platforms, Biotechnology · Countries of operation: South Africa Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round:…


Lead party: Alitheia Capital Limited (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Cipher Genetics, Inc. (private company) · Sector: Healthcare, Digital Health Platforms, Biotechnology · Countries of operation: South Africa

Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Series A · Deal amount: US$2.5m

Lead investor/buyer: Alitheia Capital Limited · Investors/buyers: Alitheia Capital Limited

Legal advisers: not identified in the source record.

Source: announced 20 December 2019. Original announcement: disruptafrica.com.